The following table details the insider trading activities
(stock purchases, stock sales, and stock option exercises) of Pauls Dietrich John since 2018.
This trader's CIK number is 1760123.
At the time of last reporting, Pauls Dietrich John was the President and CEO of Diamedica Therapeutics Inc.. (stock ticker symbol DMAC).
Also see all insider trading activities at Diamedica Therapeutics Inc..
| Insider Buying | Insider Sales | Option Exercises | |||||
|---|---|---|---|---|---|---|---|
| Year | Symbol | Shares | Value | Shares | Value | Shares | Value |
| 2023 | DMAC | 12,787 | $49,997 | 0 | $0 | 0 | $0 |
| 2022 | DMAC | 20,000 | $24,200 | 0 | $0 | 0 | $0 |
| 2021 | DMAC | 5,000 | $15,700 | 0 | $0 | 0 | $0 |
| 2019 | DMAC | 1,000 | $2,677 | 0 | $0 | 0 | $0 |
| 2018 | DMAC | 5,000 | $20,000 | 0 | $0 | 0 | $0 |
| Trade Date | Symbol | Trade Type | Shares | Price ($) | Value ($) |
|---|---|---|---|---|---|
| 2023-06-23 | DMAC | Buy | 12,787 | 3.91 | 49,997 |
| 2022-11-16 | DMAX | Buy | 20,000 | 1.21 | 24,200 |
| 2021-08-16 | DMAC | Buy | 5,000 | 3.14 | 15,700 |
| 2019-08-16 | DMAC | Buy | 1,000 | 2.68 | 2,677 |
| 2018-12-11 | DMAC | Buy | 5,000 | 4.00 | 20,000 |
Insider trading activities including stock purchases, stock sales, and option exercises listed in the above table cannot be completely guaranteed as to their accuracy. For more information regarding the trades made by Pauls Dietrich John (President and CEO of Diamedica Therapeutics Inc. at the time of this reporting) see the Securities and Exchange Commission (SEC) website.